top of page

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...
JMG Logo transparent.png
Executive Spotlights

CeriBell upsizes IPO, targets $578M valuation

  • Oct 9, 2024
  • 1 min read

Fargo, ND, October 9, 2024 (Reuters) -- CeriBell is aiming for a valuation of up to $578.3 million, aiming to raise $180 million by offering approximately 10.6 million shares at $16 to $17 each. The move reflects robust investor confidence in the healthcare sector, bolstered by strong recent IPO performances. Backed by TPG, CeriBell's offering showcases the increasing appetite for healthcare startups among investors.


Read full article here.

 
 
 

Recent Posts

See All
Qlaris Bio Appoints Fred Guerard as CEO

Dedham, MA, March 1, 2026 (Business Wire) -- Qlaris Bio has appointed Fred Guerard, Pharm.D., as president and chief executive officer, effective March 1, 2026, and he will also join the company’s b

 
 
 

Comments


Life Science Headlines
bottom of page